Clinical Trial
Journal Article
Research Support, Non-U.S. Gov't
Add like
Add dislike
Add to saved papers

Polyethylene wear and osteolysis with a new modular titanium acetabular component: results at 7 to 13 years.

The first-generation and second-generation modular titanium fiber-metal acetabular components were notable for high rates of pelvic osteolysis and liner dislodgment. This is a prospective, consecutive study of 111 new modular titanium-fiber metal acetabular components with a novel polyethylene locking mechanism at a mean follow-up of 9.5 years (range, 7-13 years). The polyethylene was gamma-irradiated in air in 58 hips and gamma-irradiated in nitrogen in 54 hips. No acetabular component migrated, none were revised, and there was no liner dislodgment. Pelvic osteolysis was seen in only 2 hips. The mean linear wear rate was 0.085 mm/y (range, 0.001-0.3 mm/y). There was a significantly lower rate of wear with polyethylene liners sterilized by gamma-irradiation in nitrogen (P = .0001). The high rate of success and low rate of polyethylene wear and pelvic osteolysis at this length of follow-up may be related to the new design features of this modular acetabular component.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app